Vascular Stents Market Key Players Analysis 2031
Vascular stents are small wired net tubes that used to treat narrow or blocked arteries to improve blood flow in the arteries. The method for placement of a vascular stent into the body is called as vascular stenting. The stents are usually made up of fabric and metal that used in a procedure called percutaneous coronary intervention or angioplasty that commonly used in a management of coronary artery disease, renal (kidney) artery narrowing, peripheral vascular diseases, diabetes and others. A vascular stent is placed into a blood vessel that allowing normal flow of blood and helps to reduce the chances of heart attack and chest pain.
MARKET SCOPE
The "Global Vascular Stents Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of the vascular stents market with detailed market segmentation by type, end user, and geography. The report provides key statistics on the market status of the leading vascular stents market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on type, the market is segmented into coronary stents, peripheral stents, EVAR stent grafts.
- Based on the end user the market is segmented as hospitals, cardiac centers, ambulatory surgical centers.
MARKET DYNAMICS
Drivers
- Rising minimally invasive procedures
- Growing innovations in stenting technologies
- Rising incidence of vascular diseases
Restraints
- Availability of alternative treatment methods for vascular diseases
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The vascular stents market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the vascular stents market in these regions.
IMPACT OF COVID-19 ON VASCULAR STENTS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 pandemic significantly impacted the market for vascular stents. According to a 2021 report by Censis Technologies, Inc., many elective surgeries were postponed due to the pandemic. However, when they resumed, operating rooms and technicians had to deal with a huge backlog, while continuing to work around COVID. This unveiled the need for effective vascular stents as sterile supply processing and equipment shortages became an issue.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The vascular stents market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the vascular stents market in these regions.
IMPACT OF COVID-19 ON VASCULAR STENTS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 pandemic significantly impacted the market for vascular stents. According to a 2021 report by Censis Technologies, Inc., many elective surgeries were postponed due to the pandemic. However, when they resumed, operating rooms and technicians had to deal with a huge backlog, while continuing to work around COVID. This unveiled the need for effective vascular stents as sterile supply processing and equipment shortages became an issue.
MARKET PLAYERS
The report covers key developments in the vascular stents market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from vascular stents market are anticipated to lucrative growth opportunities in the future with the rising demand for vascular stents in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the vascular stents market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Medtronic
- Boston Scientific Corporation
- B. Braun Melsungen AG
- TERUMO CORPORATION
- JOTEC GmbH
- Lombard Medical
- C. R. Bard, Inc.
- Meril Life Sciences Pvt. Ltd.
- ENDOLOGIX, INC.
- MicroPort Scientific Corporation
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Vascular Stents Market - By Type
1.3.2 Vascular Stents Market - By End User
1.3.3 Vascular Stents Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. VASCULAR STENTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. VASCULAR STENTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. VASCULAR STENTS MARKET - GLOBAL MARKET ANALYSIS
6.1. VASCULAR STENTS - GLOBAL MARKET OVERVIEW
6.2. VASCULAR STENTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. VASCULAR STENTS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. CORONARY STENTS
7.3.1. Overview
7.3.2. Coronary stents Market Forecast and Analysis
7.4. PERIPHERAL STENTS
7.4.1. Overview
7.4.2. Peripheral stents Market Forecast and Analysis
7.5. EVAR STENT GRAFTS
7.5.1. Overview
7.5.2. Evar stent grafts Market Forecast and Analysis
8. VASCULAR STENTS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CARDIAC CENTERS
8.4.1. Overview
8.4.2. Cardiac centers Market Forecast and Analysis
8.5. AMBULATORY SURGICAL CENTERS
8.5.1. Overview
8.5.2. Ambulatory surgical centers Market Forecast and Analysis
9. VASCULAR STENTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Vascular Stents Market Overview
9.1.2 North America Vascular Stents Market Forecasts and Analysis
9.1.3 North America Vascular Stents Market Forecasts and Analysis - By Type
9.1.4 North America Vascular Stents Market Forecasts and Analysis - By End User
9.1.5 North America Vascular Stents Market Forecasts and Analysis - By Countries
9.1.5.1 United States Vascular Stents Market
9.1.5.1.1 United States Vascular Stents Market by Type
9.1.5.1.2 United States Vascular Stents Market by End User
9.1.5.2 Canada Vascular Stents Market
9.1.5.2.1 Canada Vascular Stents Market by Type
9.1.5.2.2 Canada Vascular Stents Market by End User
9.1.5.3 Mexico Vascular Stents Market
9.1.5.3.1 Mexico Vascular Stents Market by Type
9.1.5.3.2 Mexico Vascular Stents Market by End User
9.2. EUROPE
9.2.1 Europe Vascular Stents Market Overview
9.2.2 Europe Vascular Stents Market Forecasts and Analysis
9.2.3 Europe Vascular Stents Market Forecasts and Analysis - By Type
9.2.4 Europe Vascular Stents Market Forecasts and Analysis - By End User
9.2.5 Europe Vascular Stents Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Vascular Stents Market
9.2.5.1.1 Germany Vascular Stents Market by Type
9.2.5.1.2 Germany Vascular Stents Market by End User
9.2.5.2 France Vascular Stents Market
9.2.5.2.1 France Vascular Stents Market by Type
9.2.5.2.2 France Vascular Stents Market by End User
9.2.5.3 Italy Vascular Stents Market
9.2.5.3.1 Italy Vascular Stents Market by Type
9.2.5.3.2 Italy Vascular Stents Market by End User
9.2.5.4 Spain Vascular Stents Market
9.2.5.4.1 Spain Vascular Stents Market by Type
9.2.5.4.2 Spain Vascular Stents Market by End User
9.2.5.5 United Kingdom Vascular Stents Market
9.2.5.5.1 United Kingdom Vascular Stents Market by Type
9.2.5.5.2 United Kingdom Vascular Stents Market by End User
9.2.5.6 Rest of Europe Vascular Stents Market
9.2.5.6.1 Rest of Europe Vascular Stents Market by Type
9.2.5.6.2 Rest of Europe Vascular Stents Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Vascular Stents Market Overview
9.3.2 Asia-Pacific Vascular Stents Market Forecasts and Analysis
9.3.3 Asia-Pacific Vascular Stents Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Vascular Stents Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Vascular Stents Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Vascular Stents Market
9.3.5.1.1 Australia Vascular Stents Market by Type
9.3.5.1.2 Australia Vascular Stents Market by End User
9.3.5.2 China Vascular Stents Market
9.3.5.2.1 China Vascular Stents Market by Type
9.3.5.2.2 China Vascular Stents Market by End User
9.3.5.3 India Vascular Stents Market
9.3.5.3.1 India Vascular Stents Market by Type
9.3.5.3.2 India Vascular Stents Market by End User
9.3.5.4 Japan Vascular Stents Market
9.3.5.4.1 Japan Vascular Stents Market by Type
9.3.5.4.2 Japan Vascular Stents Market by End User
9.3.5.5 South Korea Vascular Stents Market
9.3.5.5.1 South Korea Vascular Stents Market by Type
9.3.5.5.2 South Korea Vascular Stents Market by End User
9.3.5.6 Rest of Asia-Pacific Vascular Stents Market
9.3.5.6.1 Rest of Asia-Pacific Vascular Stents Market by Type
9.3.5.6.2 Rest of Asia-Pacific Vascular Stents Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Vascular Stents Market Overview
9.4.2 Middle East and Africa Vascular Stents Market Forecasts and Analysis
9.4.3 Middle East and Africa Vascular Stents Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Vascular Stents Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Vascular Stents Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Vascular Stents Market
9.4.5.1.1 South Africa Vascular Stents Market by Type
9.4.5.1.2 South Africa Vascular Stents Market by End User
9.4.5.2 Saudi Arabia Vascular Stents Market
9.4.5.2.1 Saudi Arabia Vascular Stents Market by Type
9.4.5.2.2 Saudi Arabia Vascular Stents Market by End User
9.4.5.3 U.A.E Vascular Stents Market
9.4.5.3.1 U.A.E Vascular Stents Market by Type
9.4.5.3.2 U.A.E Vascular Stents Market by End User
9.4.5.4 Rest of Middle East and Africa Vascular Stents Market
9.4.5.4.1 Rest of Middle East and Africa Vascular Stents Market by Type
9.4.5.4.2 Rest of Middle East and Africa Vascular Stents Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Vascular Stents Market Overview
9.5.2 South and Central America Vascular Stents Market Forecasts and Analysis
9.5.3 South and Central America Vascular Stents Market Forecasts and Analysis - By Type
9.5.4 South and Central America Vascular Stents Market Forecasts and Analysis - By End User
9.5.5 South and Central America Vascular Stents Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Vascular Stents Market
9.5.5.1.1 Brazil Vascular Stents Market by Type
9.5.5.1.2 Brazil Vascular Stents Market by End User
9.5.5.2 Argentina Vascular Stents Market
9.5.5.2.1 Argentina Vascular Stents Market by Type
9.5.5.2.2 Argentina Vascular Stents Market by End User
9.5.5.3 Rest of South and Central America Vascular Stents Market
9.5.5.3.1 Rest of South and Central America Vascular Stents Market by Type
9.5.5.3.2 Rest of South and Central America Vascular Stents Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL VASCULAR STENTS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. VASCULAR STENTS MARKET, KEY COMPANY PROFILES
12.1. MERIL LIFE SCIENCES PVT. LTD.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. B. BRAUN MELSUNGEN AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. JOTEC GMBH
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BOSTON SCIENTIFIC CORPORATION
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. C. R. BARD
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. LOMBARD MEDICAL
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MEDTRONIC PLC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MICROPORT SCIENTIFIC CORPORATION
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TERUMO CORPORATION
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ENDOLOGIX, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Medtronic
2. Boston Scientific Corporation
3. B. Braun Melsungen AG
4. TERUMO CORPORATION
5. JOTEC GmbH
6. Lombard Medical
7. C. R. Bard, Inc.
8. Meril Life Sciences Pvt. Ltd.
9. ENDOLOGIX, INC.
10. MicroPort Scientific Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.